Literature DB >> 17548579

A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.

Stanimir Ivanov1, Ana-Maria Dragoi, Xin Wang, Corrado Dallacosta, Jennifer Louten, Giovanna Musco, Giovanni Sitia, George S Yap, Yinsheng Wan, Christine A Biron, Marco E Bianchi, Haichao Wang, Wen-Ming Chu.   

Abstract

CpG-DNA or its synthetic analog CpG-ODN activates innate immunity through Toll-like receptor 9 (TLR9). However, the mechanism of TLR9 activation by CpG-DNA remains elusive. Here we have identified HMGB1 as a CpG-ODN-binding protein. HMGB1 interacts and preassociates with TLR9 in the endoplasmic reticulum-Golgi intermediate compartment (ERGIC), and hastens TLR9's redistribution to early endosomes in response to CpG-ODN. CpG-ODN stimulates macrophages and dendritic cells to secrete HMGB1; in turn, extracellular HMGB1 accelerates the delivery of CpG-ODNs to its receptor, leading to a TLR9-dependent augmentation of IL-6, IL-12, and TNFalpha secretion. Loss of HMGB1 leads to a defect in the IL-6, IL-12, TNFalpha, and iNOS response to CpG-ODN. However, lack of intracellular TLR9-associated HMGB1 can be compensated by extracellular HMGB1. Thus, the DNA-binding protein HMGB1 shuttles in and out of immune cells and regulates inflammatory responses to CpG-DNA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548579      PMCID: PMC1976374          DOI: 10.1182/blood-2006-09-044776

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  60 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials.

Authors:  S W Lee; M K Song; K H Baek; Y Park; J K Kim; C H Lee; H K Cheong; C Cheong; Y C Sung
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

3.  HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.

Authors:  Man Yu; Haichao Wang; Aihao Ding; Douglas T Golenbock; Eicke Latz; Christopher J Czura; Matthew J Fenton; Kevin J Tracey; Huan Yang
Journal:  Shock       Date:  2006-08       Impact factor: 3.454

4.  Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.

Authors:  M Bauer; V Redecke; J W Ellwart; B Scherer; J P Kremer; H Wagner; G B Lipford
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

5.  DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA.

Authors:  W Chu; X Gong; Z Li; K Takabayashi; H Ouyang; Y Chen; A Lois; D J Chen; G C Li; M Karin; E Raz
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

6.  Antagonism of immunostimulatory CpG-oligodeoxynucleotides by 4-aminoquinolines and other weak bases: mechanistic studies.

Authors:  L Manzel; L Strekowski; F M Ismail; J C Smith; D E Macfarlane
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

7.  Development of dendritic cells in vitro from murine fetal liver-derived lineage phenotype-negative c-kit(+) hematopoietic progenitor cells.

Authors:  Y Zhang; Y Wang; M Ogata; S Hashimoto; N Onai; K Matsushima
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

8.  Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells.

Authors:  Ingrid E Dumitriu; Paramita Baruah; Marco E Bianchi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  Eur J Immunol       Date:  2005-07       Impact factor: 5.532

9.  The p58-positive pre-golgi intermediates consist of distinct subpopulations of particles that show differential binding of COPI and COPII coats and contain vacuolar H(+)-ATPase.

Authors:  M Ying; T Flatmark; J Saraste
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

10.  Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.

Authors:  H Häcker; R M Vabulas; O Takeuchi; K Hoshino; S Akira; H Wagner
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  204 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.

Authors:  Hulda Sigridur Hreggvidsdóttir; Anna M Lundberg; Ann-Charlotte Aveberger; Lena Klevenvall; Ulf Andersson; Helena Erlandsson Harris
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

3.  Special delivery: granulin brings CpG DNA to Toll-like receptor 9.

Authors:  Eva Marie Y Moresco; Bruce Beutler
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

Review 4.  Impaired clearance of apoptotic cells in germinal centers: implications for loss of B cell tolerance and induction of autoimmunity.

Authors:  Ziaur S M Rahman
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

Review 5.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

6.  Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice.

Authors:  Ru Liu-Bryan; Robert Terkeltaub
Journal:  Arthritis Rheum       Date:  2010-07

7.  Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses.

Authors:  Daniela Giordano; Chang Li; Mehul S Suthar; Kevin E Draves; Daphne Y Ma; Michael Gale; Edward A Clark
Journal:  J Leukoc Biol       Date:  2010-12-22       Impact factor: 4.962

Review 8.  The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.

Authors:  Lei Wu; Lili Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

9.  Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1.

Authors:  Shu Zhu; Wei Li; Jianhua Li; Andrew E Sama; Haichao Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-20

Review 10.  Trafficking of endosomal Toll-like receptors.

Authors:  Bettina L Lee; Gregory M Barton
Journal:  Trends Cell Biol       Date:  2014-01-15       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.